Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 94 USD 2.42%
Market Cap: 4.8B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Haemonetics Corp
Interest Income Expense Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Interest Income Expense
-$8.5m
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
2%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Interest Income Expense
-$82m
CAGR 3-Years
-17%
CAGR 5-Years
-101%
CAGR 10-Years
-4%
ICU Medical Inc
NASDAQ:ICUI
Interest Income Expense
-$105.9m
CAGR 3-Years
-709%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Interest Income Expense
$16.7m
CAGR 3-Years
83%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Interest Income Expense
$15m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Interest Income Expense
-$4.8m
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
7%

See Also

What is Haemonetics Corp's Interest Income Expense?
Interest Income Expense
-8.5m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Interest Income Expense amounts to -8.5m USD.

What is Haemonetics Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
2%

Over the last year, the Interest Income Expense growth was -3%. The average annual Interest Income Expense growth rates for Haemonetics Corp have been 23% over the past three years , 9% over the past five years , and 2% over the past ten years .

Back to Top